Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Dyserythropoiesis in the diagnosis of the myelodysplastic syndromes and other myeloid neoplasms: problem areas.

Goasguen JE, Bennett JM, Bain BJ, Brunning R, Vallespi MT, Tomonaga M, Zini G, Renault A; (The International Working Group on Morphology of MDS).

Br J Haematol. 2018 Aug;182(4):526-533. doi: 10.1111/bjh.15435. Epub 2018 Jun 19.

PMID:
29917221
2.

Quality control initiative on the evaluation of the dysmegakaryopoiesis in myeloid neoplasms: Difficulties in the assessment of dysplasia.

Goasguen JE, Bennett JM, Bain BJ, Brunning RD, Vallespí MT, Tomonaga M, Zini G, Renault A; International Working Group on Morphology of MDS IWGM-MDS.

Leuk Res. 2016 Jun;45:75-81. doi: 10.1016/j.leukres.2016.04.009. Epub 2016 Apr 11.

3.

Proposal for refining the definition of dysgranulopoiesis in acute myeloid leukemia and myelodysplastic syndromes.

Goasguen JE, Bennett JM, Bain BJ, Brunning R, Vallespi MT, Tomonaga M, Zini G, Renault A; International Working Group on Morphology of MDS (IWGM-MDS).

Leuk Res. 2014 Apr;38(4):447-53. doi: 10.1016/j.leukres.2013.12.020. Epub 2013 Dec 29.

PMID:
24439566
4.

Morphological evaluation of monocytes and their precursors.

Goasguen JE, Bennett JM, Bain BJ, Vallespi T, Brunning R, Mufti GJ; International Working Group on Morphology of Myelodysplastic Syndrome.

Haematologica. 2009 Jul;94(7):994-7. doi: 10.3324/haematol.2008.005421. Epub 2009 Jun 16.

5.

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, Harris NL, Le Beau MM, Hellström-Lindberg E, Tefferi A, Bloomfield CD.

Blood. 2009 Jul 30;114(5):937-51. doi: 10.1182/blood-2009-03-209262. Epub 2009 Apr 8. Review.

6.

Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts.

Mufti GJ, Bennett JM, Goasguen J, Bain BJ, Baumann I, Brunning R, Cazzola M, Fenaux P, Germing U, Hellström-Lindberg E, Jinnai I, Manabe A, Matsuda A, Niemeyer CM, Sanz G, Tomonaga M, Vallespi T, Yoshimi A; International Working Group on Morphology of Myelodysplastic Syndrome.

Haematologica. 2008 Nov;93(11):1712-7. doi: 10.3324/haematol.13405. Epub 2008 Oct 6.

7.

A case of systemic histoplasmosis diagnosed in a peripheral blood smear.

Mesa H, Pambuccian S, Ferrieri P, Brunning R.

Br J Haematol. 2004 Nov;127(3):241. No abstract available.

PMID:
15491282
8.

Neutrophils in the gray platelet syndrome.

White JG, Brunning RD.

Platelets. 2004 Aug;15(5):333-40.

PMID:
15370105
9.

Classification of acute leukemias.

Brunning RD.

Semin Diagn Pathol. 2003 Aug;20(3):142-53. Review.

PMID:
14552428
10.

MDS--new classification, new problem?

Brunning RD.

Leuk Res. 2003 Jul;27(7):567-9. No abstract available.

PMID:
12681354
11.

Follicular pattern of bone marrow involvement by follicular lymphoma.

Torlakovic E, Torlakovic G, Brunning RD.

Am J Clin Pathol. 2002 Nov;118(5):780-6.

PMID:
12428800
12.

The value of anti-pax-5 immunostaining in routinely fixed and paraffin-embedded sections: a novel pan pre-B and B-cell marker.

Torlakovic E, Torlakovic G, Nguyen PL, Brunning RD, Delabie J.

Am J Surg Pathol. 2002 Oct;26(10):1343-50.

PMID:
12360049
13.

The World Health Organization (WHO) classification of the myeloid neoplasms.

Vardiman JW, Harris NL, Brunning RD.

Blood. 2002 Oct 1;100(7):2292-302. Review.

14.

Myelodysplastic syndromes: from French-American-British to World Health Organization: a commentary.

Bennett JM, Brunning RD, Vardiman JW.

Blood. 2002 Apr 15;99(8):3074-5. No abstract available.

15.

Diagnostic criteria and classification of mastocytosis: a consensus proposal.

Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, Marone G, Nuñez R, Akin C, Sotlar K, Sperr WR, Wolff K, Brunning RD, Parwaresch RM, Austen KF, Lennert K, Metcalfe DD, Vardiman JW, Bennett JM.

Leuk Res. 2001 Jul;25(7):603-25. Review.

PMID:
11377686
16.

Langerhans cell histiocytosis.

Brunning RD.

Br J Haematol. 2000 Dec;111(3):717. No abstract available.

PMID:
11122128
17.

Malignant histiocytosis.

Brunning RD.

Br J Haematol. 1999 Dec;107(4):679. No abstract available.

PMID:
10606869
18.

bcl-1 gene rearrangements in mantle cell lymphoma: a comprehensive analysis of 118 cases, including B-5-fixed tissue, by polymerase chain reaction and Southern transfer analysis.

Chibbar R, Leung K, McCormick S, Ritzkalla K, Strickler J, Staggs R, Poppema S, Brunning RD, McGlennen RC.

Mod Pathol. 1998 Nov;11(11):1089-97.

PMID:
9831207
19.

Demonstration of clonality in neutrophils using FISH in a case of chronic neutrophilic leukemia.

Froberg MK, Brunning RD, Dorion P, Litz CE, Torlakovic E.

Leukemia. 1998 Apr;12(4):623-6.

PMID:
9557623
20.

Correlation of PCR-detected clonal gene rearrangements with bone marrow morphology in patients with B-lineage lymphomas.

Coad JE, Olson DJ, Christensen DR, Lander TA, Chibbar R, McGlennen RC, Brunning RD.

Am J Surg Pathol. 1997 Sep;21(9):1047-56.

PMID:
9298881
21.

Posttransplant T-cell lymphoproliferative disorders--an aggressive, late complication of solid-organ transplantation.

Hanson MN, Morrison VA, Peterson BA, Stieglbauer KT, Kubic VL, McCormick SR, McGlennen RC, Manivel JC, Brunning RD, Litz CE.

Blood. 1996 Nov 1;88(9):3626-33.

22.

Acute leukemia and the transient myeloproliferative disorder associated with Down syndrome: morphologic, immunophenotypic and cytogenetic manifestations.

Litz CE, Davies S, Brunning RD, Kueck B, Parkin JL, Gajl Peczalska K, Arthur DC.

Leukemia. 1995 Sep;9(9):1432-9.

PMID:
7658708
23.
25.

L3 acute lymphoblastic leukemia. Comparison with small noncleaved cell lymphoma involving the bone marrow.

Dayton VD, Arthur DC, Gajl-Peczalska KJ, Brunning R.

Am J Clin Pathol. 1994 Feb;101(2):130-9.

PMID:
8116566
26.

Morphologic and quantitative alterations in hematopoietic cells associated with growth factor therapy: review of the literature.

Schmitz LL, Litz CE, Brunning RD.

Hematol Pathol. 1994;8(3):55-73. Review. No abstract available.

PMID:
7527020
27.

Morphologic and quantitative changes in blood and marrow cells following growth factor therapy.

Schmitz LL, McClure JS, Litz CE, Dayton V, Weisdorf DJ, Parkin JL, Brunning RD.

Am J Clin Pathol. 1994 Jan;101(1):67-75.

PMID:
7506481
28.

Chronic lymphoproliferative disorders: classification and diagnosis.

Litz CE, Brunning RD.

Baillieres Clin Haematol. 1993 Dec;6(4):767-83. Review.

PMID:
8038489
29.

A proposed staging system for chronic myeloid leukemia.

Ross DW, Brunning RD, Kantarjian HM, Koeffler HP, Ozer H.

Cancer. 1993 Jun 1;71(11):3788-91.

PMID:
8490930
30.

Duplication of small segments within the major breakpoint cluster region in chronic myelogenous leukemia.

Litz CE, McClure JS, Copenhaver CM, Brunning RD.

Blood. 1993 Mar 15;81(6):1567-72.

31.

Severe aplastic anemia preceding acute lymphoblastic leukemia.

Matloub YH, Brunning RD, Arthur DC, Ramsay NK.

Cancer. 1993 Jan 1;71(1):264-8. Review.

PMID:
8416724
32.

Methylation status of the major breakpoint cluster region in Philadelphia chromosome negative leukemias.

Litz CE, McClure JS, Coad JE, Goldfarb AN, Brunning RD.

Leukemia. 1992 Jan;6(1):35-41.

PMID:
1346543
33.

T-prolymphocytic leukemia.

Brunning RD.

Blood. 1991 Dec 15;78(12):3111-3. No abstract available.

34.

Transformation of chronic lymphocytic leukemia to small non-cleaved cell lymphoma: a cytogenetic, immunological, and molecular study.

Litz CE, Arthur DC, Gajl-Peczalska KJ, Rausch D, Copenhaver C, Coad JE, Brunning RD.

Leukemia. 1991 Nov;5(11):972-8.

PMID:
1961039
35.

Acute basophilic leukemia. A clinical, morphologic, and cytogenetic study of eight cases.

Peterson LC, Parkin JL, Arthur DC, Brunning RD.

Am J Clin Pathol. 1991 Aug;96(2):160-70.

PMID:
1862771
36.

The morphologic and immunophenotypic assessment of the lymphocytosis accompanying Bordetella pertussis infection.

Kubic VL, Kubic PT, Brunning RD.

Am J Clin Pathol. 1991 Jun;95(6):809-15.

PMID:
2042590
37.

Identification of novel B-lineage cells in human fetal bone marrow that coexpress CD7.

Grümayer ER, Griesinger F, Hummell DS, Brunning RD, Kersey JH.

Blood. 1991 Jan 1;77(1):64-8.

38.

Oligoclonal T cell receptor gene rearrangements in blood lymphocytes of patients with acute Epstein-Barr virus-induced infectious mononucleosis.

Strickler JG, Movahed LA, Gajl-Peczalska KJ, Horwitz CA, Brunning RD, Weiss LM.

J Clin Invest. 1990 Oct;86(4):1358-63.

39.

Presence of cell lineage-specific hypomethylated sites in the major breakpoint cluster region.

Litz CE, Goldfarb AN, Strickler JG, Brunning RD.

Cancer Res. 1990 Aug 15;50(16):4984-90.

40.

Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.

Cheson BD, Cassileth PA, Head DR, Schiffer CA, Bennett JM, Bloomfield CD, Brunning R, Gale RP, Grever MR, Keating MJ, et al.

J Clin Oncol. 1990 May;8(5):813-9. Review.

PMID:
2185339
41.

Refractory anemia with excess of blasts in transformation hematologic and clinical study of 52 patients.

Michels SD, Saumur J, Arthur DC, Robison LL, Brunning RD.

Cancer. 1989 Dec 1;64(11):2340-6.

PMID:
2804925
43.

Myelodysplasia and acute leukemia following treatment for Hodgkin's disease.

McKenna RW, Brunning RD.

Am J Clin Pathol. 1989 Jul;92(1):127-8. No abstract available.

PMID:
2750703
44.

Mature T-lineage leukemia with growth factor-induced multilineage differentiation.

Griesinger F, Arthur DC, Brunning R, Parkin JL, Ochoa AC, Miller WJ, Wilkowski CW, Greenberg JM, Hurvitz C, Kersey JH.

J Exp Med. 1989 Mar 1;169(3):1101-20.

45.

Establishment of a leukemic cell line MT-ALL with multilineage differentiation potential.

Griesinger F, Greenberg JM, Arthur DC, Ochoa AC, Hurvitz C, Brunning R, Kersey JH.

Haematol Blood Transfus. 1989;32:214-9. No abstract available.

PMID:
2696679
46.

Establishment of a leukemic cell model for studying human pre-B to B cell differentiation.

Wörmann B, Anderson JM, Liberty JA, Gajl-Peczalska K, Brunning RD, Silberman TL, Arthur DC, LeBien TW.

J Immunol. 1989 Jan 1;142(1):110-7.

PMID:
2642502
47.

Allogeneic bone marrow transplantation for acute nonlymphocytic leukemia in first remission.

McGlave PB, Haake RJ, Bostrom BC, Brunning R, Hurd DD, Kim TH, Nesbit ME, Vercellotti GM, Weisdorf D, Woods WG, et al.

Blood. 1988 Nov;72(5):1512-7.

48.

Systemic polyclonal immunoblastic proliferations.

Peterson LC, Kueck B, Arthur DC, Dedeker K, Brunning RD.

Cancer. 1988 Apr 1;61(7):1350-8.

PMID:
3278799
49.

Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia.

Yunis JJ, Lobell M, Arnesen MA, Oken MM, Mayer MG, Rydell RE, Brunning RD.

Br J Haematol. 1988 Feb;68(2):189-94.

PMID:
3162379
50.

Central nervous system involvement in acute nonlymphocytic leukemia. A prospective study of adults in remission.

Peterson BA, Brunning RD, Bloomfield CD, Hurd DD, Gau JA, Peng GT, Goldman AI.

Am J Med. 1987 Sep;83(3):464-70.

PMID:
3661583

Supplemental Content

Loading ...
Support Center